High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice

Transgenic Research

Volumn 17, Issue 4, 2008, Pages 727-732

  Tang, Bo ^a   Yu, Shanshan ^a   Zheng, Min ^b   Ding, Fangrong ^b   Zhao, Rui ^b   Zhao, Jianmin ^b   Dai, Yunping ^a   Li, Ning ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Beijing Wanger Biotechnology Company Ltd   (China)

Author keywords

Anti CD20; Expression; Milk; Monoclonal antibody; Transgenic

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB;

ANIMAL; ARTICLE; B CELL LYMPHOMA; FEMALE; GENETICS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MALE; METABOLISM; MILK; MOUSE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, B-CELL; MALE; MICE; MICE, TRANSGENIC; MILK;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 46649085058     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-007-9162-3     Document Type: Article

References (26)

1. Adams GP, Weiner LM (2005) Monoclonal antibody therapy of cancer. Nat Biotechnol 23:1147-1157
2. Boye J, Elter T, Engert A (2003) An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 14:520-535
3. Cragg MS, Glennie MJ (2004) Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents. Blood 103:2738-2743
4. Farid SS (2007) Process economics of industrial monoclonal antibody manufacture. J Chromatogr B 848:8-18
5. Flieger D, Renoth S, Beier I, Sauerbruch T, Schmidt-Wolf I (2000) Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol 204:55-63
6. Gavin WG, Pollock D, Fell P, Yelton D, Cammuso C, Harrington M, Lewis-Williams J, Midura P, Oliver A, Smith TE, Wilburn B, Echelard Y, Meade H (1997) Expression of the antibody hBR96-2 in the milk of transgenic mice and production of hBR96-2 transgenic goats. Theriogenology 47:214
7. Hieter PA, Max EE, Seidman JG, Maizel Jr JV, Leder P (1980) Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell 22:197-207
8. Houdebine LM (2002) Antibody manufacture in transgenic animals and comparisons with other systems. Curr Opin Biotechnol 13:625-629
9. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C (1991) Sequences of proteins of immunological interest, 5th edn. National Institutes of Health Publication, Bethesda, MD
10. Kolb AF, Pewe L, Webster J, Perlman S, Whitelaw CBA, Siddel SG (2001) Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis. J Virol 75:2803-2809
11. Limonta J, Pedraza A, Rodriguez A, Freyre FM, Barral AM, Castro FO, Lleonart R, Gracia CA, Gavilondo JV, de la Fuente J (1995) Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice. Immunotechnology 1:107-113
12. Mitchell ER, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood l83:435-445
13. Mohrbacher A (2005) B cell non-Hodgkin's lymphoma: rituximab safety experience. Arthritis Res Ther 7:19-25
14. Pescovitz MD (2006) Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859-866
15. Pollock DP, Kutzko JP, Birck-Wilson E, Williams JL, Echelard Y, Meade HM (1999) Transgenic milk as a method for the production of recombinant antibodies. J Immunol Methods 231:147-157
16. Reichert JM, Pavlou A (2004) Monoclonal antibodies market. Nat Rev Drug Discov 7:383-384
17. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody success in the clinic. Nat Biotechnol 23:1073-1078
18. Sola I, Castilla J, Pintado B, Sanchez-Morgado JM, Whitelaw CB, Clark AJ, Enjuanes L (1998) Transgenic mice secreting coronavirus neutralizing antibodies into the milk. J Virol 72:3762-3772
19. Sommerfeld S, Strube J (2005) Challenges in biotechnology production-generic processes and process optimization for monoclonal antibodies. Chem Eng Process 44:1123-1137
20. Stern M, Herrmann R (2005) Overview of monoclonal antibodies in cancer therapy: present and promise. Crit Rev Oncol Hematol 54:11-29
21. Takahashi N, Ueda S, Obata M, Nikaido T, Nakai S, Honjo T (1982) Structure of human immunoglobulin gamma genes: implications for evolution of a gene family. Cell 29:671-679
22. Talbot D, Collis P, Antoniou M, Vida M, Grosveld F, Greaves DR (1989) A dominant control region from the human β-globin locus conferring integration site-independent gene expression. Nature 338:352-355
23. van Kuik-Romeijn P, de Groot N, Hooijberg E, de Boer HA (2000) Expression of a functional mouse-human chimeric anti-CD19 antibody in the milk of transgenic mice. Transgenic Res 9:155-159
24. World Health Organization. World Health Report 2000. http://www.who.int
25. Young MW, Meade H, Curling JM, Ziomek CA, Harvey M (1998) Production of recombinant antibodies in the milk of transgenic animals. Res Immunol 149:609-610
26. Yu S, Liang M, Fan B, Xu H, Li C, Zhang Q, Li D, Tang B, Li S, Dai Y, Wang M, Zheng M, Yan B, Zhu Q, Li N (2006) Maternally derived recombinant human anti-Hantavirus monoclonal antibodies are transferred to mouse offspring during lactation and neutralize virus in vitro. J Virol 80:4183-4186